| Overview |
| bsm-62005r-cy3-100ul |
| Dlx5 Recombinant Antibody, Cy3 Conjugated |
| WB, IF(ICC) |
| Human, Mouse, Rat |
| Specifications |
| Cy3 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human DLX5 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 1749 |
| P56178 |
| Nucleus |
| Distal less homeo box 5; Dlx 5; Homeo box protein DLX 5. |
| Transcriptional factor involved in bone development. Acts as an immediate early BMP-responsive transcriptional activator essential for osteoblast differentiation. Stimulates ALPL promoter activity in a RUNX2-independent manner during osteoblast differentiation. Stimulates SP7 promoter activity during osteoblast differentiation. |
| Application Dilution |
| WB |
1:300-5000 |
| IF(ICC) |
1:50-200 |
Powered by Bioz